Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
$13.35
-3.19%
(-0.44) 1D
$13.35
0.00% (0.00)
After hours
Closed: Apr 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
$13.79
High
$14.00
Low
$13.27
Mkt. cap
387.41M
Avg. vol.
135.78K
Volume
0.00
52-wk high
$17.15
52-wk low
$4.96
EPS
-$3.20
Beta
1.00
Shares outstanding
29.02M
No. of employees
120
News stories
From sources across the web
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websiteenanta.com
Last report
Feb 9, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-0.42/ (-0.88 est.)USD
+52.05%beat
Revenue / Estimate
18.62M/ (15.31M est.)USD
+21.57%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
14.93M
18.31M
15.12M
18.62M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.06M
27.21M
23.81M
20.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.39M
10.00M
9.70M
9.01M
Operating expense
39.45M
37.21M
33.51M
29.87M
Total operating expenses
39.45M
37.21M
33.51M
29.87M
Operating income
-24.53M
-18.89M
-18.39M
-11.25M
Other non operating income
-
-
39.00K
-
EBT including unusual items
-23.95M
-18.23M
-18.67M
-11.91M
EBT excluding unusual items
-23.95M
-18.23M
-19.63M
-11.89M
Income tax expense
-1.30M
29.00K
32.00K
24.00K
Effective tax rate
5.45%
-0.16%
-0.17%
-0.20%
Other operating expenses
-
-
-
-
Net income
-22.64M
-18.26M
-18.70M
-11.94M
Net profit margin
-151.71%
-99.68%
-123.64%
-64.13%
Earnings per share
-1.06
-0.85
-0.87
-0.42
Interest and investment income
2.29M
2.28M
1.11M
2.44M
Interest expense
-1.71M
-1.62M
-2.39M
-3.08M
Net interest expenses
578.00K
667.00K
-1.28M
-641.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.32M
-17.68M
-17.10M
-10.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more